Literature DB >> 81837

Immunological studies on pancreatic phospholipase A2. Antigenic characterization of the NH2-terminal region.

H Meijer, M J Meddens, R Dijkman, A J Slotboom, G H de Haas.   

Abstract

Rabbit antisera elicited against pure pig, horse, ox, and sheep pancreatic phospholipase A2 revealed considerable immunological differences when tested by double immunodiffusion and microcomplement fixation assays. Snake venom phospholipases did not show any detectable cross-reactions with the pancreatic enzymes. Microcomplement fixation also clearly demonstrated conformational differences between porcine phospholipase A2 and its zymogen. NH2 terminally modified analogs of porcine phospholipase A2 could be clearly distinguished using the same assay. Moreover, strong evidence was obtained that Ala1-Arg6 is a part of an antigenic determinant. Radioimmune assay, using monovalent phospholipase-specific Fab fragments revealed a maximum number of three antigenic sites of phospholipase that can simultaneously be occupied by antibody. The Fab fragments were separated into three fractions, using three immunoadsorbent columns in series. These Fab fractions showed different inhibitory properties toward micellar binding of phospholipase A2. They also exhibited different protective effects against active center modification.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 81837

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Immunocytochemical localization of phospholipase A2 in hamster spermatozoa.

Authors:  M Riffo; E Gómez Lahoz; P Esponda
Journal:  Histochemistry       Date:  1992

2.  Expression of porcine pancreatic phospholipase A2. Generation of active enzyme by sequence-specific cleavage of a hybrid protein from Escherichia coli.

Authors:  P de Geus; C J van den Bergh; O Kuipers; H M Verheij; W P Hoekstra; G H de Haas
Journal:  Nucleic Acids Res       Date:  1987-05-11       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.